Hospira, Inc., a leading global provider of injectable drugs and infusion technologies, has launched its infusion pump multithérapeutique Sapphire on the European market. Sapphire is an infusion pump light and compact that can be used in hospital settings, ambulatory and home.

The infusion pump is launched at the 18th Congress of the European Association of Hospital Pharmacists (EAHP).

The device features includes a broad intuitive color touch screen designed for quick and easy programming. Control technology is integrated magnetic flow in peristaltic pumping system of Sapphire, and this technology ensures the continuity of low-flow pumping. The pump is designed to deliver drugs with high accuracy during the treatment, to reduce energy consumption and provide longer battery autonomy. It includes methods for brewing all possible uses and simplifies the treatment of patients treated in different clinical areas.

Hospira launches Sapphire pump on the European market after announcing an agreement with Q Core Medical, Ltd. was concluded in January for the international distribution of the product. With this agreement, Hospira is authorized to market and distribute the infusion pump over 60 markets. This unit can be ordered immediately in France, Italy and the UK and will be available later on in other European markets. Hospira's dominance in the field of technology infusion, combined with the strengths of the pump Sapphire, offer many benefits to purchasing clients infusion pumps, as well as patients from using them.

"The fact that the system adds qu'Hospira Sapphire its product portfolio expands its management medication that was already extensive. It also reflects the company's commitment in the field of medical devices. The pump responds to the diverse needs essential drug delivery environments hospital, ambulatory and home, but it is also able to quickly and easily adapt to emerging needs,” said Svend Andersen, president for the Europe, Middle East and Africa at Hospira. "The marketing agreement and distribution agreement for the pump Sapphire enhances our ability to support patient safety the main regions of the world.”